Quick Answer
CERO THERAPEUTICS HOLDINGS, INC. reported Stockholders Equity of -$1.89 million for fiscal year 2024.
CERO THERAPEUTICS HOLDINGS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | -$1.89M | +95.5% |
| 2023 | -$42.06M | -282.3% |
| 2022 | -$11.00M | -43.4% |
| 2021 | -$7.67M | — |
| 2021 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$4.54M | — | -178.1% |
| June 30, 2025 | -$1.63M | +34.2% | -396.0% |
| March 31, 2025 | -$329.4K | +91.7% | +82.6% |
| December 31, 2024 | -$1.89M | +95.5% | +23.7% |
| June 30, 2024 | -$2.48M | +81.3% | +37.6% |
| March 31, 2024 | -$3.98M | +65.6% | +90.5% |
| December 31, 2023 | -$42.06M | -282.3% | -205.5% |
| September 30, 2023 | -$13.77M | -52.0% | -3.6% |
- CERO THERAPEUTICS HOLDINGS, INC. showed an increase of +95.5% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from CERO THERAPEUTICS HOLDINGS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: